Research Article

Proinflammation and Hypertension: A Population-Based Study

Table 1

Baseline characteristics of 396 baseline normotensive subjects according tohypertension status at the end of the follow-up period. HT−: normotensive at the end of study, HT+: hypertensive at the end of study (blood pressure ≥140/90 mmHg and/or antihypertensive drug use), and CVD: cardiovascular disease.

HT−HT+ P

Number of female = 249/396 (63%)180 (67%)69 (54%)
Age (years) 53.0 ± 51<.001
Follow-up time (years) .091
BMI (kg/ ) 11
IL-1β (pg/mL) .020
IL-1ra (pg/mL)154 ± 89184 ± 1327
Lipid-lowering drug at the beginning of the study1%3%.091
Lipid-lowering drug at the end of the study9%26%<.001
Drug for some other CVD at the end of the study3%6%.398
Smoking30%26%.807
Alcohol > 10 units/week%5%6%.807
Physically active25%33%.086